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Abstract 
Leprosy is an infectious disease caused by bacteria Mycobacterium leprae. The research aimed at investigating 
the hemoglobin and ferritin serum levels on the leprosy patients compared with the healthy control group, 
whether the anemia occurred on the leprosy patients. The research was conducted in Dr. Wahidin Sudirohusodo 
Hospital and other hospitals in Makassar City from April to July 2017. The research used the analytic 
observational method with the case control study design. Samples were the leprosy patients and the control 
group of 18 - 52 years old who came to be treated to the dermatovenereology of Dr. Wahidin Sudirohusodo 
Hospital and other hospitals in Makassar City. As many as 37 samples consisted of 19 samples of the leprosy 
patients and 18 samples of the control group.  
----------------------------------------------------------------------- 
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Blood from the vein of mediana cubiti was taken, the hemoglobin examination was carried out using the 
hematology analyzer and the ferritin serum was conducted using ELFA technique to find out every level. The 
research result indicates that the mean hemoglobin level on the leprosy patients is 13.1H.9 gr/dl lower than the 
control group with 14.2±1.3 gr/dl, the ferritin serum level is higher on the leprosy patients with the mean of 
236.9±204.9 than the control group with 132.9±85.4. From 37 samples, the lowest hemoglobin level is 9.5 gr/dl, 
and the highest is 16.3 gr/dl with the mean of 13.6±1.7 gr/dl, the lowest ferritin serum level is 6.5 pg/ml, and the 
highest is 692.5 pg/dl with the mean of 186.3±165.0 pg/dl. 
Keywords: Leprosy; hemoglobin level; ferritin serum level; anemia. 
1. Introduction  
Leprosy or Hansen's disease, is a chronic granulomatous bacterial infection that primarily affects the peripheral 
nerves and may subsequently attack skin, oral mucosa, upper airway, reticuloendothelial system, eyes, muscles, 
bones and testes except the central nervous system [1]. 
The bacterial that causes leprosy is Mycobacterium leprae or Hansen's germ, which was first identified by the 
Norwegian physician, Gerhard HenrikArmauer Hansen in 1873. 
Globally, there is an upward trend in both leprosy prevalence and in the detection of new leprosy cases in 2012 
to mid-2013. In Indonesia, the number of new cases detected in 2011 until 2012 appears to have declined 
slightly, with 22.390 cases in 2011 and 18.994 cases in 2012. Based on this report, most cases (82.6%) are 
multibacillary leprosy (MB) [2]. 
Chronic infectious diseases such as leprosy can cause anemia on its course. The changes in the formation of 
erythrocytes (eritropoiesis) results in anemia due to inflammatory process or better known as anemia of chronic 
diseases. Clinical features of anemia of chronic disease,are often asymptomatic and obscured by clinical 
symptoms of its underlying disease, thus requiring further evaluation. Anemia due to chronic disease occurs in 
patients with acute or chronic immune activity, so-called anemia of inflammation. 
Leprosy is an infectious disease caused by Mycobacterium leprae,an intracellular obligate bacteria. All bacteria 
require a purine base from the nucleotides in order to make nucleic acids and also for oxidative metabolism. 
Unlike other mycobacteria, M. leprae cannot synthesize and may obtain it from a host cell. Mycobacteria also 
requireiron that they extract and procure it from the host through chelation with mycobactin. Iron is 
indispensable in various metabolic processes such as oxygen transport, DNA synthesis and transport of electrons 
as essential nutrients. Iron is also imperative as an energy cofactor in mitochondrial respiration, proliferation and 
activation of T lymphocytes, B lymphocytes, and Natural Killer cells. 
Intake of iron from host tissue plays an important role for the development of pathogenic bacteria in vivo. The 
limited amounts of iron in the host trigger bacteria to take iron reserves from transferrin and lactoferrin, or from 
ferritin. Mycobacteria produces an iron-binding molecule (siderofor) called mycobactin, exochelin, and 
carboxymycobactin, which then stores it in the form of bacterioferritin. Gram-positive mycobacteria tend to 
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acquire iron-bound hemerather than ferritin, in which heme is the largest iron-binding protein in the body 
(80%). Mycobacteria have the ability to prevent phagosome maturation, thus providing an appropriate 
environment for the bacteria to grow. 
Reduced iron reserves will decrease cell mediated immuneresponse such as delayed hypersensitivity, 
lymphocyte proliferation due to antigen stimulation, natural killer cytotoxicity and others. The presence of iron 
at the cellular level is required in the differentiation and proliferation of Th-1 and Th-2. Th-1 is more sensitive 
to antitransferrin antibody receptor, with the end result inhibition of DNA synthesis. Th-2 is relatively more 
resistant to these antibodies. It is therefore suspected that Th-1-mediated function is more sensitive to iron 
hemostasis in the body. Ferritin is the main protein associated with iron deposits by macrophages and 
hepatocyte cells. In 1997, it was proven that MDT therapy in less than 24 months was effective, thus the 
recommended duration was 1 year for MB leprosy [3]. Until now, early detection and therapy with MDT is still 
a major strategy in reducing the burden of disease caused by leprosy. MDT also succeeds in shortening the 
duration of infectivity thereby reducing the risk of subsequent transmission to a healthy person in the 
community. Previous study by Dogra and his colleagues [4], conducted on 730 MB leprosy patients in northern 
India who were treated with MDT for 12 months showed clinical, bacteriology and histopathological 
improvement in almost all patients. As far as the author's knowledge, there has been no study that reported 
hemoglobin and serumferritin levels in leprosy patients prior to MDT-WHO therapy compared to healthy 
controls. Hemoglobin and ferritin serum levels prior to therapy of subjects who met the inclusion criteria based 
on WHO were measured, in which the results were monitored and assessed.  Based on the above background, 
this study aims to determine the levels of hemoglobin and serum ferritin in leprosy patients compared to healthy 
control and the incidence of anemia in leprosy patients. 
2. Material and Methods 
Time and Place  
2017. The study was conducted in theDermatovenereology Department of Dr.WahidinSudirohusodo Hospital, 
Hasanuddin University Hospital,TajuddinKhalid Hospital and other networking hospitals in Makassar as 
sampling places. The study was conducted in April 2017 to July 
Design Study and Variable 
The research used the analytic observational method with the case control study design. The study variables 
consisted of: independent variable (leprosy patients pre MDT-WHO), dependent variable (hemoglobin and 
ferritin serum levels), intermediate variable (Mycobacteriumleprae, iron, erythrocytes), and confounding 
variable (food intake). 
Population and Sample 
The population of this study is leprosy patients who have not received MDT-WHO therapy who came to 
Dermatovenereology Department of Dr.WahidinSudirohusodo Hospital, Hasanuddin University Hospital 
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Makassar, Tajuddin Khalid Hospital Makassar and other networking hospitals. The study sample was the entire 
affordable population that met the inclusion criteria. 
Data Collection 
Every subjects who came to Dermatovenereology department and met the inclusion criteria were recorded and 
then history taking and physical examination were performed to establish the diagnosis of leprosy and photos of 
the subject were taken. After the patient signs the informed consent, a blood specimen was collected to 
determine the hemoglobin levels using hematology analyzer and serum ferritin levels using ELFA technique. 
The data obtained then analyzed and reported in the results. 
Data Analysis 
The collected data was processed and presented in the form of tables and graphics. Data analysis was performed 
using SPSS version 22.0 system with Independent sample t test and Mann Whitney test with p <0.05 
significance. 
3. Results 
An analytic observational approach with case control study was conducted to determine hemoglobin and serum 
ferritin levels in leprosy patients compared to healthy control and to determine the incidence of anemia. The 
study was executed atdermatovenereology clinic of Dr.WahidinSudirohusodoHospital Makassar, Hasanuddin 
University Hospital Makassar, Tajuddin Khalid Hospital Makassar and other networking hospitals from April to 
July 2017. Total samples were 37 subjects, consisted of 19 new leprosy patients with no history of previous 
therapy and 18 healthy subjects as the control group. The subjects aged 18 - 52 years old with the mean age 
29.4; 25 men and 12 women with Hb levels ranged from 9.5 to 16.3 gr% with mean of 13.6 gr / dl and serum 
ferritin level ranged from 6.5-692.5 gr / dL with mean of 186.3 gr / dL; the results of serum ferritin levels were 
variable (attachment, Table 1). 
Table 1: Sampel Characteristics 
Variabelis N % Min/Maks Mean ± SD 
Age 37 100,0% 18/52 29,4±10,6 
Sex Male 25 67,6% - - 
Female 12 32,4% - - 
Group Leprosy 19 51,4% - - 
Control 18 48,6% - - 
Hb level (gr/dl) 37 100,0% 9,5/16,3 13,6±1,7 
Ferritin serum level (ng/ml) 37 100,0% 6,5/692,5 186,3±165,0 
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Anova One-Way analysis showed that there was no significant difference in serum ferritin levels based on age 
group. While,there was a significant difference (p <0.05) in hemoglobin level based on sex group; Hb levels 
were higher in males (14.3 ± 14 g / dl) than in women (12.1 ± 1.1 g / dl). However, there was no significant 
difference (p> 0.05) for serum ferritin levels, with the tendency of male serum ferritin levels (207.8 ± 159.0) 
were higher than women (141.5 ± 175.1) (attachment, Table 2). 
Table 2: Serum Ferritin dan Hemoglobin level comparison based on Characteristics Demografi 
Variabel 
Serum Ferritin level Hb level 
Mean±SD P Mean±SD P 
 
Age 
(years) 
<20 (n=9) 128,5±111,8  
0,691* 
13,2±1,2  
0,866* 
21-30 (n=16) 212,3±213,3 13,7±1,9 
31-40 (n=6) 197,5±174,4 13,7±1,8 
>40 (n=6) 192,3±26,0 13,8±2,0 
sex Men (n=25) 207,8±159,0 0,258*
* 
14,3±1,4 0,001*
* Female (n=12) 141,5±175,1 12.1±1.1 
*One-Way Anova; **Independent sample t test 
 
Comparative analysis of serum ferritin levels and hemoglobin based on dietary intake group using Mann 
Whitney test showed that there was no significant difference.Although, serum ferritin level in leprosy groupwith 
mean of 236.9 ± 204.9 were higher than control group with mean of 132.9 ± 85.4. Hemoglobin of leprosy 
groupwith mean of 13.1 ± 1.9 was lower than control group with mean of 14.2 ± 1.3, but this result was not 
statistically significant. There was significant difference (p <0.05) of Hb level based on food intake group; Hb 
level were higher in good intake (13.9 ± 1.6gr / dl) than in poor intake (11.5 ± 0.8 g / dl) (attachment, Table 3). 
Table 3: Serum Ferritin leveland Hemoglobin levelcomparison based on group and food intake 
Variabel 
Kadar serum ferritin Kadar Hb 
Mean±SD P Mean±SD p 
 
Group 
Leprosy(n=19) 236,9±204,9 0,245* 13,1±1,9 0,057* 
Control(n=18) 132,9±85,4 14,2±1,3 
 
Food intake 
Good (n=33) 164,9±126,8 0,380* 13,9±1,6 0,004* 
Poor (n=4) 362,3±329,5 11,5±0,8 
*Mann Whitney;  
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Based on combination of leprosy group and intake group results, this study showed that Hb levels were 
influenced by leprosy status and intake. Highest Hb concentration was observed in control subject with good 
intake (14.3 ± 1.3 gr%) and lowest on leprosy subject with poor intake (11.2 ± 07 gr%), with Mann Whitney test 
showed significant differences ( p <0.05). 
Spearman correlation test showed significant correlation (p <0.05) with correlation coefficient equal to r = 
0.460, in combination of leprosy status and intake; indicates that the more the two factors are found (leprosy + 
poor intake), the lower Hb level (attachment, Table 4). 
Table 4: Hemoglobin level comparisonbased onleprosy andfood intake combination 
Kombinasi MH dan Asupan 
Kadar Hb 
P 
Min/maks (Med) Mean (SD) 
Control+good food intake  n=17 12,0/15,9(14,6) 14,3(1,3)aa  
0,025 
Leprosy+ good food intake n=16 9,5/16,3(13,8) 13,4(1,8)ab 
Control+ poor food intake  n=1 12,3 12,3ab 
Leprosy+poor food intake n=3 10,5/11,8(11,2) 11,2(0,7)bb 
MH=….Kruskal Wallis+Mann-Whitney U test; SpearmanCorrelation  
 
Comparison of serum ferritin levels based on combination of leprosy status and dietary intakeshowed that serum 
ferritin levels were not significantly affected (p> 0.05). 
The serum ferritin levels of leprosy subjects with poor intake was high (476.8 ± 290.3) and low on non- leprosy 
subjects with good intake (139.6 ± 83.0), nonethelessit was not statistically significantsince  serum ferritin in 
each group varies greatly. Moreover, Spearman correlation test showed a non-significant correlation (p>0.05) 
with correlation coefficient equal to r = 0,160; indicates that the more the two factors are found(leprosy + poor 
intake), the higher serum ferritin level (attachment, Table 5). 
Table 5: Ferritin Serum level comparison based on leprosy and food intake 
Kombinasi MH dan Asupan 
Kadar Serum Feritin 
P 
Min/maks (Med) Mean (SD) 
Control+ good food intake n=17 14,6/258,1(102,9) 139,6(83,0)  
0,114 
Leprosy+ good food intake n=16 9,5/16,3(166,6) 191,9(159,6) 
Control+ poor food intake n=1 18,7(18,7) 18,7 
Leprosy+ poor food intake  n=3 146,8/692,5(591,2) 476,8(290,3) 
Kruskal Wallis; SpearmanCorrelation (r=0,160 p=0,176) 
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4. Discussion 
This study showed that mean hemoglobin level in leprosy patients was 13.1 ± 1.9 gr / dl, lower than control 
group 14.2 ± 1.3 gr / dl; serum ferritin levels were higher in leprosy patients with mean 236.9 ± 204.9 than 
control group 132.9 ± 85.4. Of 37 samples, the lowest hemoglobin level was 9.5 gr / dl and the highest was 16.3 
gr / dl with mean of 13.6 ± 1.7 g / dl; the lowest serum ferritin level was 6.5 gr / dl and the highest 692.5 gr / dl 
with the mean of 186.3 ± 165.0 gr / dl. 
The levels of hemoglobin basedon sex group showed hemoglobin level in men was higher with mean of 14.3 ± 
1.4 gr / dl compared to women with mean of 12.1 ± 1.1 gr / dl, this result was proved significant with 
independent sample t test for hemoglobin level(p <0.05). Serum ferritin levels in males was higher with mean of 
207.8 ± 159.0 ng / ml compared to women with mean of 141,5 ± 175,1 ng / ml, but statistically not significant. 
Based on the age group there was no significant difference in hemoglobin level, whereas the mean value of 
serum ferritin level at 21-30 years old was higher while the lowest was at under 20 years old. 
There were more of male leprosy patients than female and the largest number of leprosy patients aged between 
21-30 years old. The sex and age of all subjects,the leprosy and control group were homogeneous in this study, 
and no significant differences were obtained. This is in accordance with the literature which states that the 
prevalence of leprosy is higher in men than women, especially since men are more susceptible to lepromatous 
leprosy and tend to seek treatment [5]. Leprosy can affect all ages, the most encountered between 10-20 years 
and 30-60 years. Leprosy in adult population living in endemic area is often a reinfection or superinfection of an 
individual that previously infected but subclinicallyundergo decreasing immune response as they grow older. 
Levels of hemoglobin in leprosy patients were lower with mean of 13.1 ± 1.9 gr / dl compared to control group 
with mean of 14.2 ± 1.3 gr / dl, while serum ferritin level of leprosy patients was higher with mean of236.9 ± 
204. 9 ng / ml compared to control with mean of 132.9 ± 85.4, however these results were not significant 
statistically. Hemoglobin levels based on food intake in both groups of samples, hemoglobin levels were higher 
in good food intake with mean of 13.9 ± 1.6 g / dl compared to poor food intake with mean of 11.5 ± 0.8 gr / dl 
and there was a significant difference using the Mann Whitney test. A study reported that anemia is often found 
in patients with either tuberculoidor lepromatous leprosy, however anemia were not severe and no erythrocyte 
morphological abnormalities were found. Anemia is a condition of decreased function and quality of 
hemoglobin. 
Control group with good food intake had higher hemoglobin level with mean of 14.6 gr / dl compared to leprosy 
patients with good food intake with mean of 13.8 gr / dl, and lowest hemoglobin level was found in leprosy 
patient with poor intake with an average of 11.2 gr / dl, this result was statistically significant using Spearman 
correlation test. Control group with good food intake had lower serum ferritin level with mean of 102.9 ng / ml 
compared to leprosy patients with good food intake with mean of 166.6 ng / ml, whereas in leprosy patients with 
poor food intake had the highest serum ferritin level at 591.2 ng / ml, but this result was not found significant. 
Nutrients play a role in the formation of red blood cells (erythropoesis)since iron (Fe), folic acid and vitamin B-
12are needed for the process of erythopoesis. A person is at risk of anemia when there is shortage of these 
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substances. There are some interventions to prevent anemia, such as consuming foodthat rich in iron, food 
containing iron / heme is very bioavailable; especially red meat, poultry and fish. The body procures iron from 
food metabolism in the gut. Iron obtained from food is released in the stomach through the action of peptic 
enzymes and stomach acid. Iron passes through the duodenum, the site of maximum absorption of iron. Each 
iron feri (Fe3 +) will be converted to a form of fero (Fe2 +) by a membrane enzyme, cytochrome B in the 
duodenum. The ferrous iron can then bind to divalent metal in the membrane (divalent metal transporter-1) to 
enter the enterocytes. In order to be absorbed by the body, iron must pass through the enterocytes and then exit 
using feroportin then can be released to plasma transferrin. This process requires changing iron again into a feri 
shape with the help of some auxiliary proteins. If the removal of iron from enterocytes does not occur then iron 
is converted to ferritin. Ferritin will disappear along with the release of enterocytes into the intestinal lumen [6]. 
Leprosy is a chronic infectious disease caused by M. lepraethat primarily attacks peripheral nerves and may 
subsequently attack the skin, oral mucosa, upper airway, reticuloendothelial system, eyes, muscles, bones and 
testes except the central nervous system.Leprosy has a broad clinical spectrum that is related to the 
immunological response of the host, both natural immune responses and adaptive immune responses. The 
function of T cells and antibodies in the immunologic response to leprosy are influenced by the role of various 
cytokines [7]. Ferritin is the major protein associated with iron deposits by macrophages and hepatocyte cells. In 
chronic disease anemia there is a decrease in the number of reticulocytes and serum erythropoietin levels, iron 
concentrations may be normal to declined; serum transferrin levels may be decreased or normal; and serum 
ferritin levels may be normal or elevated. Anemia due to chronic disease occurs due to iron homeostais 
disorders which there isan increase in uptake and retention of iron in reticuloendothelial cells (RES). Iron will 
be stored in many RES cells hence the availability of iron for proliferation of erythroid progenitor cells, 
forerythropoetin production and the lifespan of red blood cells will be disrupted. According to WHO, cases of 
anemia occur in tropical and sub-tropical areas such as Asia and Africa, mainly cause by chronic conditions 
with long course of disease (iron deficiency or chronic disease) [8]. The proinflammatory stimulus also induces 
iron retention in the macrophages through resistance to feroportin expression thus no iron removal from 
macrophages occurs. IL-10 will accelerate the accumulation of iron in transferrin-enriched macrophages as well 
as stimulate the expression of ferritin. TNF-α will promote degradation and erythrocyte phagocytosis by 
macrophages. TNF-α, IL-1, IL-6, IL-10 together will stimulate the expression of ferritin, increasing iron storage 
and retention within the macrophages. There is also a blockage of erithropoetin production in the kidneys by 
TNF-α and IFN-γ. The availability of iron in the circulation will be limited with decreased activity of 
erythropoietin therefore inhibit erythropoesis resulting in anemia [9]. 
5. Conclusion 
The authors concluded that hemoglobin levels in leprosy patients were lower than in the control group. Serum 
ferritin levels in leprosy patients were higher than in the control group. Leprosy patients with good food intake 
have higher hemoglobin levels than leprosy patients with poor food intake. While the control group with good 
food intake had higher hemoglobin levels than leprosy patients, with significant results. Researchers suggest that 
leprosy patients need to have good food intake. Further research is needed to assess hemoglobin and serum 
ferritin levels in leprosy patients after MDT-WHO therapy. 
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